STING1 and cancer: An analysis of TCGA data sets also revealed that STING expression is positively correlated with the infiltration of almost all immune cells, including MDSCs and Tregs, in pan-cancer, especially in bladder urothelial carcinoma, breast cancer, liver hepatocellular carcinoma, prostate adenocarcinoma and thyroid carcinoma [165].